Cell death at the millennium: Implications for liver diseases

Clinics in Liver Disease

Volumn 4, Issue 1, 2000, Pages 1-23

  Kaplowitz, Neil ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; APOPTOSIS INDUCING FACTOR; CALPAIN; CASPASE; CATHEPSIN B; CERAMIDE; CYCLOSPORIN A; CYTOKINE; FAS ANTIGEN; FAS LIGAND; GRANZYME B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; NITRIC OXIDE; PARACETAMOL; PROTEIN; PROTEIN BCL 2; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SILENCER OF DEATH DOMAIN PROTEIN; TRANSCRIPTION FACTOR AP 1; TRIFLUOPERAZINE; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

APOPTOSIS; CELL DEATH; DNA DAMAGE; HUMAN; HYPOXIA; LIVER DISEASE; LIVER MITOCHONDRION; LIVER PROTECTION; LIVER TOXICITY; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

EID: 0034424972     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(05)70094-5     Document Type: Article

References (123)

1. The Bcl-2 protein family: Arbiters of cell survival
2. CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface Fas ligand expression and amplifies Fas-mediated hepatocyte death during allograft rejection
3. Death receptors: Signaling and modulation
4. L serve an anti-inflammatory function in endothelial cells through inhibition of NF-κB
5. Chronic ethanol feeding increases apoptosis and cell proliferation in rat liver
6. Protection in the late stages of paracetamol-induced liver cell injury with fructose, cyclosporin A and trifluoperazine
7. An essential role for NF-κB in preventing TNF-α-induced cell death
8. Subcellular changes and apoptosis induced by ethanol in rat liver
9. Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes
10. Acetaminophen hepatotoxicity in tumor necrosis factor/lymphotoxin-α gene knockout mice
11. Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: A mechanism of UDCA cytoprotection
12. Mechanisms of hepatic toxicity. I. TNF-induced liver injury
13. The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release
14. Akt promoted cell survival by phosphorylating and inhibiting a forkhead transcription factor
15. Superoxide in apoptosis
16. Regulation of cell death protease caspase 9 by phosphorylation
17. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control
18. Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor
19. Transport of reduced glutathione in hepatic mitochondria and mitoplasts from ethanol-treated rats: Effect of membrane physical properties and S-adenosyl-L-methionine
20. Modulation of caspase-3 activity and Fas ligand mRNA expression in rat liver cells in vivo by alcohol and lipopolysaccharide
21. RAIDD is a new 'death' adaptor molecule
22. Bcl-2 activates the transcription factor NFκB through the degradation of the cytoplasmic inhibitor IκBα
23. Intracellular ATP levels determine cell death fate by apoptosis or necrosis
24. Death receptors in liver biology and pathology
25. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas
26. GSH transport in mitochondria: Defense against TNF-induced oxidative stress and alcohol-induced defect
27. Mitochondrial glutathione: Importance and transport
28. Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL
29. Inhibition of p53 transcriptional activity by Bcl-2 requires its membrane-anchoring domain
30. Apoptosis meets signal transduction: Elimination of a BAD influence
31. Involvement of the CD95 (APO-l/Fas) receptor and ligand in liver damage
32. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species
33. Ceramide induces cytochrome c release from isolated mitochondria
34. Apoptotic bodies in a murine model of alcoholic liver disease: Reversibility of ethanol-induced changes
35. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity
36. Induction of the mitochondrial permeability transition as a mechanism of liver injury during cholestasis: A potential role for mitochondrial proteases
37. Apoptosis pathways: The roads to ruin
38. Mitochondria and apoptosis
39. L prevents this release but not tumor necrosis factor-R1/Fas death
40. Dual regulation of caspase activity by hydrogen peroxide: Implications for apoptosis
41. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C
42. The apoptosis-necrosis paradox. Apoptosis proteases activated after mitochondrial permeability transition determine the mode of cell death
43. Ceramide in apoptosis - Does it really matter?
44. NFκB prevents apoptosis and liver dysfunction during liver regeneration
45. Glutathione peroxidase-deficient mice are more susceptible to neutrophil-mediated hepatic parenchymaI cell injury during endotoxemia: Importance of an intracellular oxidant stress
46. BCL-2 blocks perforin-induced nuclear translocation of granzymes concomitant with protection against the nuclear events of apoptosis
47. Apoptosis in human hepatoma cell lines by chemotherapeutic drugs via Fas-dependent pathways
48. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains
49. Oxidative stress and liver disease
50. Caspase-independent cell killing by Fas-associated protein with death domain
51. Shrinkage necrosis: A distinct mode of cellular death
52. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
53. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-α-induced apoptosis by inducing heat shock protein 70 expression
54. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms
55. Calpain mediates ischemic injury of the liver through modulation of apoptosis and necrosis
56. Essential roles of the Fas ligand in the development of hepatitis
57. The proto-oncogene Bcl-2 and its role in regulating apoptosis
58. Hepatocytes in the bile duct-ligated rat express Bcl-2
59. ICE-protease inhibitors block murine liver injury and apoptosis by CD95 or by TNF-α
60. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice
61. Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen
62. Parenchymal cell apoptosis as a signal for sinusoidal sequestration and transendothelial migration of neutrophils in murine models of endotoxin and Fas-antibody-induced liver injury
63. Mitochondrial permeability transition during hypothermic to normothermic reperfusion in rat liver demonstrated by the protective effect of cyclosporin A
64. Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins
65. Breakthroughs and views. The shape of cell death
66. Intracellular adenosine triphosphate (ATP) concentration: A switch in the decision between apoptosis and necrosis
67. Inhibition of caspase induces a switch from apoptosis to necrosis
68. Mechanisms of hepatic toxicity v. necrapoptosis and the mitochondrial permeability transition: Shared pathways to necrosis and apoptosis
69. Nitric oxide reversibly inhibits seven members of the caspase family via S-Nitrosylation
70. Cleavage of BID caspase 8 mediates the mitochondrial damage pathways of apoptosis
71. Cholestasis confers resistance to the rat liver mitochondrial permeability transition
72. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
73. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis
74. Cytoprotection by Bcl-2 requires the poreforming α5 and α6 helices
75. Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs
76. Selective repopulation of normal mouse liver by Fas/CD95-resistant hepatocytes
77. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) I/Fas) receptor/ligand system and involves activation of wild-type p53
78. Regulation of CD95 (APO-I/Fas) receptor and ligand expression by lipopolysaccharide and dexamethasone in parenchymal and nonparenchymal rat liver cells
79. Apoptosis and alcoholic liver disease
80. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria
81. Lethal effects of the anti-Fas antibody in mice
82. 1
83. A model for p53-induced apoptosis
84. The mitochondrial permeability transition mediates both necrotic and apoptotic death of hepatocytes exposed to Br-A23187
85. Impaired liver regeneration in inducible nitric oxide synthase deficient mice
86. Inhibition of tumor necrosis factor (TNF-α)-mediated apoptosis by hepatitis C virus core protein
87. Protection of acetaminophen hepatocellular apoptosis and necrosis by cholesteryl hemisuccinate pretreatment
88. Bcl-2 family proteins and mitochondria
89. Control of apoptosis by the cellular ATP level
90. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation
91. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production
92. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death
93. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases
94. A comparative study of apoptosis and necrosis in HepG2 cells. Oxidant-induced caspase inactivation leads to necrosis
95. Two CD95 (APO-1/Fas) signaling pathways
96. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions
97. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF
98. TNF receptors death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase
99. A caspase-9 variant missing the catalytic site is an endogenous inhibitor of apoptosis
100. Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspase-2,-3,-6.-7,-8, and -10 in a caspase-9-dependent manner
101. Chronic ethanol-initiated apoptosis in hepatocytes is induced by changes in membrane biogenesis and intracellular transport
102. Hepatic failure and liver damage in acute Wilson's disease involve CD95 (APO-I/Fas) mediated apoptosis
103. Distinct cascades are initiated in receptors-mediated and chemical-induced apoptosis
104. Mitochondrial release of caspase-2 and -9 during the apoptotic process
105. Mitochondria as regulators of apoptosis: Doubt no more
106. Molecular characterizations of apoptosis-inducing factor
107. Cycloheximide-induced T-cell death is mediated by a Fas-associated death domain-dependent mechanism
108. Concanavalin A-induced liver cell damage: Activation of intracellular pathways triggered by tumor necrosis factor in mice
109. Concanavalin A-induced liver injury triggers hepatocyte proliferation
110. Caspase: Enemies within
111. Rapid and specific efflux of reduced glutathione during apoptosis induced by anti-Fas/APO-1 antibody
112. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
113. NF-κB antipoptosis: Induction of TRAF1 and TRAF2 and C-IAP1 and c-IAP2 to suppress caspase-8 activation
114. Movement of bax from the cytosol to mitochondria during apoptosis
115. Caspase-dependent activation of calpain during drug-induced apoptosis
116. Bcl-2-mediated resistance to apoptosis is associated with glutathione-induced inhibition of AP24 activation of nuclear DNA fragmentation
117. Ethanol-induced apoptosis to stable HepG2 cell lines expressing human cytochrome P-4502E1
118. Apoptosis and Bcl-2 protein expression in experimental alcoholic liver disease in the rat
119. Prevention of hypoxic liver cell necrosis by in vivo human bcl-2 gene transfection
120. Granzyme B mimics apical caspase
121. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3, not BCL-XL
122. Redistribution of bax from cytosol to membranes is induced by apoptosis stimuli and is an early step in the apoptotic pathway
123. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor I and enhances TNF-induced apoptosis